Benefit-Risk Evaluation: The Past, Present And Future
A short article by Juhaeri JUHAERI, VP & Head, Epidemiology and Benefit-Risk at Sanofi Keywords:…
A short article by Juhaeri JUHAERI, VP & Head, Epidemiology and Benefit-Risk at Sanofi Keywords:…
Changes the life sciences industry is going through, resulting in digital transformation within the organisations…
Narrow focus vs Global strategy concepts How to transform Regulatory Affairs to manage the increasing…
Amplify clinical outcomes with evidenced digital and pharmaceutical interventions paired together How do new technologies…
Involve your patients in CT from the beginning to ensure their needs are reflected in…
Professional Regulations experts who work in collaboration with the Commercial and Medical Teams in order…
Pharma Businesses are operating significantly better and faster relying on data How could regulatory affairs…
Why solutions that are more outcomes-oriented should be taken more seriously? What Digital Health impacts…
Paving the way to commercial excellence through adjusting to consumer’s needs and understanding their behaviour.…
Educate yourself and your company for a comprehensive evaluation of a potential partner How can…